As of 2026-08-16, the Relative Valuation of Intellipharmaceutics International Inc (IPCI.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 CAD, the upside of Intellipharmaceutics International Inc based on Relative Valuation is -136.0%.
The range of the Relative Valuation is (0.01) - (0.05) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.4x | 0.2x |
| Forward P/E multiples | 0.1x - 0.4x | 0.2x |
| Fair Price | (0.01) - (0.05) | (0.03) |
| Upside | -114.4% - -157.6% | -136.0% |
| Date | P/E |